In colonic tumours expressing low levels of MCT1, the induction of GLUT1 and the down-regulation of GLUT2 would enable the cells to take up and utilise glucose efficiently and ensure their growth and survival in the absence of their conventional energy source, butyrate. Here, SLC2A1 is linked to colonic neoplasm.